The Royal Society of Medicines, 6th ed

This is the sixth edition of Medicines: The Comprehensive Guide – the most popular and best-selling dictionary-style reference source-book for the range of medicines, along with possible side-effects, that is available in the UK today. Previous editions of this book have sold almost two million copies. The text has been extensively revised – to take account of the many new drugs, both generic and proprietary, as well as entire new drug groups, that have been developed and marketed since publication of the fifth edition in 2000. Changes in details of those medicines that remain on the market are also included. Requests from the public have led to the inclusion in this edition of expanded warnings about possible interactions between drugs with other medicines – especially those that can be obtained without a prescription –herbal remedies and nutritional supplements. There is also an expanded glossary of medical terms, which hopefully readers will find useful in understanding some of the more technical terms.

download

Read more...

Advanced Drug Design And Development: A Medicinal Chemistry Approach

This volume, entitled Advanced Drug Design and Development: A Medicinal Chemistry Approach, is a collection of lectures by most of the invited speakers in The Department of Pharmaceutical-Medicinal Chemistry, School of Pharmacy, Aristotelian University of Thessaloniki.about the newtrends in our science, through the presentations of renowned invited speakers. It is also aimed to create a forum for exchange of ideas in medicinal chemistry, in a different informal environment, bringing internationally recognized medicinal chemists closer to their Greek colleagues.

download

Read more...

Validation of Toxicogenomic Technologies

download

Toxicogenomics has been described as a discipline combining ex-pertise in toxicology, genetics, molecular biology, and environmental health to elucidate the response of living organisms to stressful environ-ments. It includes the study of how genomes respond to toxicant expo-sures and how genotype affects responses to toxicant exposures. As the technologies for monitoring these responses rapidly develop, it is critical that scientists and regulators are confident that the technologies are reliable and reproducible and that the data analyses have been validated. To discuss these issues in a public forum, the Committee on the Validation of Toxicogenomic Technologies designed a workshop to consider the current practice and advances in the validation of toxicogenomic tech-nologies. The workshop focused on the technical aspects of validation, recognizing it as a prerequisite for considering other important issues, such as biological validation (e.g., validating the use of microarray “sig-natures” to describe a toxic effect).

Read more...

Target Validation in Drug Discovery

This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessonslearned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as "second generation" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book

download

Read more...